PFBT
CGON icon

Parkside Financial Bank & Trust’s CG Oncology CGON Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42K Hold
20
– – ﹤0.01% 2301
2026
Q1 		$1.35K Hold
20
– – ﹤0.01% 2245
2025
Q4 		$831 Hold
20
– – ﹤0.01% 2401
2025
Q3 		$806 Hold
20
– – ﹤0.01% 2373
2025
Q2 		$520 Hold
20
– – ﹤0.01% 2528
2025
Q1 		$490 Buy
+20
New +$563 ﹤0.01% 2407

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's CGON Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its CG Oncology (CGON) position steady in Q2 2026 at 20 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2301.

Parkside Financial Bank & Trust first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Parkside Financial Bank & Trust held 20 shares of CG Oncology worth $1.42K as of Q2 2026.
  • Parkside Financial Bank & Trust left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2301 holding.
  • Parkside Financial Bank & Trust first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.